![Frontiers | Deregulated calcium signaling in blood cancer: Underlying mechanisms and therapeutic potential Frontiers | Deregulated calcium signaling in blood cancer: Underlying mechanisms and therapeutic potential](https://www.frontiersin.org/files/Articles/1010506/fonc-12-1010506-HTML/image_m/fonc-12-1010506-g001.jpg)
Frontiers | Deregulated calcium signaling in blood cancer: Underlying mechanisms and therapeutic potential
![Exploring the Potential of Metallodrugs as Chemotherapeutics for Triple Negative Breast Cancer - Nayeem - 2021 - Chemistry – A European Journal - Wiley Online Library Exploring the Potential of Metallodrugs as Chemotherapeutics for Triple Negative Breast Cancer - Nayeem - 2021 - Chemistry – A European Journal - Wiley Online Library](https://chemistry-europe.onlinelibrary.wiley.com/cms/asset/defe7aeb-a2a9-4270-b9c6-171bb42ed7f8/chem202100438-toc-0001-m.jpg)
Exploring the Potential of Metallodrugs as Chemotherapeutics for Triple Negative Breast Cancer - Nayeem - 2021 - Chemistry – A European Journal - Wiley Online Library
Integrated Transcriptome Profiling Identifies Prognostic Hub Genes as Therapeutic Targets of Glioblastoma: Evidenced by Bioinformatics Analysis | ACS Omega
![Frontiers | Boosting Tissue Vascularization: Nanofat as a Potential Source of Functional Microvessel Segments Frontiers | Boosting Tissue Vascularization: Nanofat as a Potential Source of Functional Microvessel Segments](https://www.frontiersin.org/files/Articles/820835/fbioe-10-820835-HTML/image_m/fbioe-10-820835-g001.jpg)
Frontiers | Boosting Tissue Vascularization: Nanofat as a Potential Source of Functional Microvessel Segments
![Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial–mesenchymal transition (EMT) to mesenchymal–epithelial transition (MET) states | British Journal of Cancer Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial–mesenchymal transition (EMT) to mesenchymal–epithelial transition (MET) states | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fbjc.2014.80/MediaObjects/41416_2014_Article_BFbjc201480_Fig1_HTML.jpg)
Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial–mesenchymal transition (EMT) to mesenchymal–epithelial transition (MET) states | British Journal of Cancer
![Cancers | Free Full-Text | NRG1/ERBB3/ERBB2 Axis Triggers Anchorage-Independent Growth of Basal-like/Triple-Negative Breast Cancer Cells Cancers | Free Full-Text | NRG1/ERBB3/ERBB2 Axis Triggers Anchorage-Independent Growth of Basal-like/Triple-Negative Breast Cancer Cells](https://www.mdpi.com/cancers/cancers-14-01603/article_deploy/html/images/cancers-14-01603-g001.png)
Cancers | Free Full-Text | NRG1/ERBB3/ERBB2 Axis Triggers Anchorage-Independent Growth of Basal-like/Triple-Negative Breast Cancer Cells
![Frontiers | KIR-HLA Functional Repertoire Influences Trastuzumab Efficiency in Patients With HER2-Positive Breast Cancer Frontiers | KIR-HLA Functional Repertoire Influences Trastuzumab Efficiency in Patients With HER2-Positive Breast Cancer](https://www.frontiersin.org/files/Articles/791958/fimmu-12-791958-HTML/image_m/fimmu-12-791958-g001.jpg)